• Skip to primary navigation
  • Skip to main content

A NEW DAY in DME Treatment

  • See If You Qualify
  • The NEW DAY Study
  • Why Participate?
  • For Healthcare Providers
  • FAQs
  • Contact Us

Why Participate?

Participating In A Clinical Research Study

A clinical research study, otherwise known as a clinical trial, is conducted by doctors and researchers. These studies are designed to conduct a scientific evaluation of identified treatment options. Throughout the study, the rights and safety of participants are always protected. The outcomes of a clinical trial can provide much-needed data to continuously improve patient treatment options in the future.

Take our survey below to see if you qualify to participate in the NEW DAY Study.

The NEW DAY Study will compare the use of short-acting and long-acting FDA-approved therapies for early diabetic macular edema.

The trial will require your participation for 18 months, if you qualify.

There will be consistent follow-up and monthly assessments throughout the duration of the study.

TAKE THE SURVEY, SEE IF YOU QUALIFY


More information also available on our FAQ page

Explore more

Footer

Privacy Policy
Privacy Shield Policy
Terms & Conditions

This site is intended for US residents only.
Copyright © 2021 Alimera Sciences, Inc. All rights reserved.